0001104659-26-020655
SEC filingRevenue grew 48% to $251.7M, driven by DDS segment surging 57%, while gross margin expanded 100 bps to 40%.
Innodata describes itself as a global data engineering and AI systems services company that partners with leading technology companies, frontier AI laboratories, and enterprises to support the development, training, post-training, evaluation, and deployment of advanced artificial intelligence systems. Founded over 35 years ago, the company began building proprietary AI language models in 2016-2017 and has since developed integrated AI lifecycle data solutions.
The company reports three operating segments: Digital Data Solutions (DDS), Synodex, and Agility. DDS encompasses the core AI data engineering and services business. Synodex is a platform that transforms medical records into structured digital data for insurance and healthcare workflows. Agility provides media intelligence and PR workflow software enhanced with AI-driven monitoring and analytics. No specific revenue percentages are given for each segment, but one DDS customer accounted for 58% of total company revenue in fiscal 2025.
Named platforms include Synodex (medical data transformation) and Agility PR Solutions (media intelligence). The company also operates Innodata Labs for long-term innovation and Technology Practices for scalable solutions, though these are internal groupings rather than commercial products.
Innodata uses a direct sales model with professional staff and senior management in the US, Canada, UK, and Europe, supplemented by selective partnerships. Customers include five of the "Magnificent Seven" tech companies and leading AI research labs. Customer concentration is high: one DDS customer represented 58% of total revenues in 2025 (48% in 2024). International revenues were 16% in 2025 and 21% in 2024, with a global delivery footprint across over 70 countries.
The market is highly competitive. Named competitors include specialized AI data firms such as Appen, CloudFactory, Surge AI, Invisible Technologies, Turing, Mercor, Define.a, TELUS Digital, and Scale AI. Broader technology and business process services competitors include Accenture, Cognizant, EXL, Genpact, Infosys, PwC, QuantumBlack, and Tata Consultancy Services. Competition is based on service quality, technical depth, scalability, and security.
Key growth strategy pillars are: expanding relationships with existing customers as their AI initiatives mature; driving new customer acquisition in existing and emerging markets, including a newly launched Federal Practice for US government agencies; developing new capabilities such as agentic trust and safety evaluation frameworks; and maintaining a long-term innovation perspective through Innodata Labs and external advisory relationships.
As of December 31, 2025, Innodata employed 10,107 people (10,020 full-time). The company also engages 12,200 professionals across over 70 countries, including centers of excellence spanning training data, alignment, evaluation, and red teaming.
Revenue for the year ended December 31, 2025 was $251.7 million, a 48% increase from $170.5 million in 2024, primarily driven by the Digital Data Solutions (DDS) segment. Gross profit rose 48.3% to $99.5 million, and gross margin improved to 40% from 39% as revenue growth outpaced direct operating cost increases. Income from operations surged 63.5% to $39.9 million, with operating margin expanding 150 basis points to 15.8%, reflecting operating leverage. Net income increased 12.2% to $32.2 million despite a higher tax provision of $9.2 million (compared to a benefit of $4.2 million in 2024). Basic earnings per share rose to $1.01 from $0.98, and diluted EPS to $0.92 from $0.89.
Management expects capital expenditures of approximately $12.1 million in 2026 for technology, platform development, and infrastructure. The company does not have material capital commitments. Cash and cash equivalents totaled $82.2 million at year-end, with working capital of $84.9 million, providing flexibility for investments and potential acquisitions. Currency exposure is partially hedged with $19.7 million in notional hedges against Philippine peso and Indian rupee. Seasonality in Synodex (lowest Q3, highest Q4) and potential wage inflation in key operating regions are noted risks. The Form S-3 shelf registration remains available for future capital raising. Overall, management emphasizes continued investment in AI capabilities and growth-oriented functions to capture demand from enterprise AI adoption.
As of December 31, 2025, the company held $82.2 million in cash and cash equivalents, a significant increase from $46.9 million a year earlier. Total assets reached $168.6 million, with stockholders' equity of $107.1 million. The company maintains a $30 million revolving credit facility with Wells Fargo, which remained undrawn at year-end. The fixed charge coverage ratio covenant was satisfied. Deferred revenue stood at $7.5 million, reflecting advance payments from customers for services to be performed within the next 12 months.
Notes to the financial statements disclose a vendor agreement for Microsoft software licenses with annual payments of approximately $0.4 million through February 2026. The remaining liability as of December 31, 2025, was only $6 thousand, indicating near-completion of that obligation. Operating lease commitments total $5.2 million in undiscounted payments, with a present value of $4.4 million. No other material purchase commitments are disclosed.
The company has a stock repurchase program authorized in July 2019 for up to $2.0 million; through year-end, $1.8 million was utilized (1.5 million shares), leaving $0.2 million remaining. There were no repurchases during fiscal 2025. No dividends have been declared or paid. Long-term obligations increased by $0.9 million to $9.3 million, primarily due to higher pension liabilities (from $7.9M to $9.3M). Capital expenditures totaled $11.1 million, or 4.4% of revenue, reflecting investments in software development and infrastructure.
The DDS segment remains the dominant driver, generating $220.8 million in revenue (87.8% of total), up 56.5% YoY, with an operating margin of 17.8%. Synodex contributed $7.3 million (2.9%), declining 6.9% as operating income fell to $0.6 million. Agility posted $23.5 million (9.3%) in revenue, up 9.4%, but reported a slight operating loss of $0.2 million. Geographically, the United States accounted for 84.3% of revenue ($212.1 million), with the remainder from Canada, UK, Netherlands, and other European countries. One customer in the DDS segment represented 58% of total revenue, highlighting concentration risk.
The most material risk is extreme customer concentration: one DDS segment customer generated 58% of FY2025 revenue and 63% of accounts receivable ($29.2M). Loss of this customer or significant volume reduction would have a material adverse effect. Revenue is also project-based with no long-term commitments; master service agreements are terminable on 30-90 days' notice.
Two significant legal matters are disclosed. A securities class action filed in February 2024 alleges false statements regarding AI technology; the Company's motion to dismiss is pending. A long-running Philippines labor dispute carries a potential judgment of ~$5.6M plus substantial accrued interest, though a US preliminary injunction currently blocks enforcement against Innodata Inc. New anti-outsourcing bills (HIRE Act, No Tax Breaks for Outsourcing Act) introduced in 2025 could penalize offshore service use if enacted.
The rapidly evolving legal landscape for artificial intelligence in the US and internationally is flagged as a key risk. Compliance with emerging regulations on governance, transparency, safety, and data provenance may increase costs and limit business practices. The Company also depends on third-party technology and data center services; any disruption could cause revenue loss and customer dissatisfaction.
Operations are heavily concentrated in the Philippines, India, Sri Lanka, and Israel, exposing the Company to political unrest, terrorism, natural calamities, and currency fluctuations. Wage inflation in Asian operations and foreign exchange volatility (revenues in CAD, GBP, EUR; expenses in local currencies) pressure margins. The Company relies on key employees, particularly the CEO, and faces intense competition for talent.
The variable-rate revolving credit facility (SOFR-based) introduces interest rate uncertainty. Restrictive covenants (e.g., fixed charge coverage ratio of 1.10:1.00) could limit operational flexibility. Quarterly revenue and earnings fluctuations are expected due to project timing and fixed cost structure. Pricing pressures from intense competition and customer demands for discounts could reduce profitability.
No cash flow statement figures were included in the provided excerpt. The document references the Consolidated Statements of Cash Flows for years ended December 31, 2025 and 2024, but the actual data is not present. Therefore, no analysis can be performed.